AlphaGrep UK’s United Therapeutics UTHR Stock Holding History

AlphaGrep UK’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$836K	Buy	1,543 +1,074	+229%	+$605K	0.25%	76
2026 Q1	$278K	Buy	+469	New	+$234K	0.08%	551

Other funds holding UTHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Norges Bank Oslo, Norway $1T AUM

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

AlphaGrep UK's UTHR Position: Q2 2026 in Review

AlphaGrep UK increased its United Therapeutics (UTHR) stake by 229% in Q2 2026, buying an estimated $605K and bringing the position to 1,543 shares worth $836K. The position accounts for 0.25% of the portfolio, ranked #76.

AlphaGrep UK first reported a position in UTHR in Q1 2026 and has held it in 2 quarters since. 818 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

AlphaGrep UK held 1,543 shares of United Therapeutics worth $836K as of Q2 2026.
AlphaGrep UK bought 1,074 United Therapeutics shares in Q2 2026, an estimated $605K.
United Therapeutics made up 0.25% of AlphaGrep UK's portfolio in Q2 2026, its #76 holding.
AlphaGrep UK first reported a position in United Therapeutics in Q1 2026 and has held it in 2 quarters since.
818 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on AlphaGrep UK's 13F filing for Q2 2026, filed 14 Aug 2026.